Technology entrepreneur, crypto expert and live leverage trader Waqar Zaka has won the TradFi Competition, a global solo ...
As the 2026 IPL season hurtles toward its conclusion, Royal Challengers Bengaluru (RCB) find themselves in a precarious position where a single result could drastically alter their postseason path.
Novo Nordisk (NVO) is rated a Modest Buy with a raised price target of $80, driven by oral Wegovy’s rapid market adoption.
Navigate every money move with guidance you can trust.
Search and explore latest news updates, photos, videos on the searched topics and terms at Hindustan Times.